Epothilone C is primarily investigated for its potential in cancer therapy due to its ability to stabilize microtubules, similar to paclitaxel, a well-known chemotherapeutic agent. This stabilization inhibits cell division, making it effective in halting the proliferation of cancer cells. It is particularly studied for its activity against drug-resistant cancers, where traditional treatments like taxanes may fail. Additionally, research explores its use in combination therapies to enhance efficacy and reduce side effects. Beyond oncology, Epothilone C is also a subject of interest in neurodegenerative disease research, as microtubule stabilization may offer therapeutic benefits in conditions like Alzheimer's disease.